Herein, we review the current findings of how a variety of accessory cells could participate in shaping the tumor microenvironment and supporting the mechanisms by which cancer cells undertake the epithelial-mesenchymal transition (EMT). EMT, a complex of phenotypic changes, promotes cancer cell invasion and creates resistance to chemotherapies. Among the accessory cells present in the EMT, immune cells (both native and adaptive) can reciprocally influence the tumor cells features, promote EMT and negatively regulate the anticancer immune response. In this review, we look over the role of EMT in crosstalk between tumor cells and the immune system, with specific emphasis on breast tumors. Finally, we suggest that understanding the role of immune cells in cancer progression could create new opportunities for diagnostic and therapeutic interventions in cancer combination therapy.
Moradpoor,R and Salimi,M . (2021). Crosstalk between Tumor Cells and Immune System Leads to Epithelial-Mesenchymal Transition Induction and Breast Cancer Progression. Iranian Biomedical Journal, 25(1), 1-7. doi: 10.29252/ibj.25.1.1
MLA
Moradpoor,R , and Salimi,M . "Crosstalk between Tumor Cells and Immune System Leads to Epithelial-Mesenchymal Transition Induction and Breast Cancer Progression", Iranian Biomedical Journal, 25, 1, 2021, 1-7. doi: 10.29252/ibj.25.1.1
HARVARD
Moradpoor R, Salimi M. (2021). 'Crosstalk between Tumor Cells and Immune System Leads to Epithelial-Mesenchymal Transition Induction and Breast Cancer Progression', Iranian Biomedical Journal, 25(1), pp. 1-7. doi: 10.29252/ibj.25.1.1
CHICAGO
R Moradpoor and M Salimi, "Crosstalk between Tumor Cells and Immune System Leads to Epithelial-Mesenchymal Transition Induction and Breast Cancer Progression," Iranian Biomedical Journal, 25 1 (2021): 1-7, doi: 10.29252/ibj.25.1.1
VANCOUVER
Moradpoor R, Salimi M. Crosstalk between Tumor Cells and Immune System Leads to Epithelial-Mesenchymal Transition Induction and Breast Cancer Progression. Iranian Biomedical Journal. 2021;25(1):1-7. doi: 10.29252/ibj.25.1.1
Iranian Biomedical Journal